Liver Diseases  >>  Sovaldi (sofosbuvir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sovaldi (sofosbuvir) / Gilead
NCT01497327: Open-Label Hepatic Impairment Study

Completed
1
24
US
PSI-352938, PSI-7977
Gilead Sciences
Hepatitis C
01/12
01/12

Download Options